Skip to content

   Pharma Publications

Neuropsychopharmacology
  • Intravenous ketamine for benzodiazepine deprescription and withdrawal management in treatment-resistant depression: a preliminary report
    Published on 2023-08-02
    2 years ago
  • Striatonigral direct pathway 2-arachidonoylglycerol contributes to ethanol effects on synaptic transmission and behavior
    Published on 2023-08-01
    2 years ago
  • The future of brain circuit-targeted therapeutics
    Published on 2023-07-31
    2 years ago
  • Temporal dynamics of neurobehavioral hormone sensitivity in a scaled-down experimental model of early pregnancy and parturition
    Published on 2023-07-31
    2 years ago
  • Swell1 channel-mediated tonic GABA release from astrocytes modulates cocaine reward
    Published on 2023-07-31
    2 years ago
  • Potential applications of temporal interference deep brain stimulation for the treatment of transdiagnostic conditions in psychiatry
    Published on 2023-07-31
    2 years ago
  • A preliminary study of the effects of an antimuscarinic agent on anxious behaviors and white matter microarchitecture in nonhuman primates
    Published on 2023-07-29
    2 years ago
« Previous 1 … 87 88 89 90 91 … 143 Next »
Journal of Psychopharmacology
  • Pharmacological evidence of a cholinergic contribution to elevated impulsivity and risky decision-making caused by adding win-paired cues to a rat gambling task
    Published on 2021-02-12
    5 years ago
  • Human perceptual learning is delayed by the N-methyl-D-aspartate receptor partial agonist D-cycloserine
    Published on 2021-02-11
    5 years ago
  • Effect of liraglutide on neural and peripheral markers of metabolic function during antipsychotic treatment in rats
    Published on 2021-02-11
    5 years ago
  • Neural and subjective effects of inhaled N,N-dimethyltryptamine in natural settings
    Published on 2021-02-11
    5 years ago
  • Responses to social evaluative stress in regular cannabis smokers
    Published on 2021-02-08
    5 years ago
  • Histamine 3 receptor inverse agonist Samelisant (SUVN-G3031): Pharmacological characterization of an investigational agent for the treatment of cognitive disorders
    Published on 2021-02-06
    5 years ago
  • Body mass index as a determinant of clozapine plasma concentrations: A pharmacokinetic-based hypothesis
    Published on 2021-02-06
    5 years ago
« Previous 1 … 87 88 89 90 91 … 134 Next »
European Neuropsychopharmacology
  • Cognitive heterogeneity is a key predictor of differential functional outcome in patients with bipolar disorder
    Published on 2021-07-11
    4 years ago
  • A proof-of-concept study of maternal immune activation mediated induction of Toll-like receptor (TLR) and inflammasome pathways leading to neuroprogressive changes and schizophrenia-like behaviours in offspring
    Published on 2021-07-11
    4 years ago
  • Treating alcohol dependence with an abuse and misuse deterrent formulation of sodium oxybate: Results of a randomised, double-blind, placebo-controlled study
    Published on 2021-07-06
    4 years ago
  • Adolescent animal models of addiction
    Published on 2021-07-06
    4 years ago
  • Type I and type II positive allosteric modulators of α7 nicotinic acetylcholine receptors induce antidepressant-like activity in mice by a mechanism involving receptor potentiation but not neurotransmitter reuptake inhibition. Correlation with mTOR intracellular pathway activation
    Published on 2021-07-06
    4 years ago
  • α2A- and α2C-adrenoceptor expression and functionality in postmortem prefrontal cortex of schizophrenia subjects
    Published on 2021-06-21
    5 years ago
  • Parkinson’s disease and REM sleep behavior disorder with special reference to cognitive decline
    Published on 2021-06-21
    5 years ago
« Previous 1 … 87 88 89 90 91 … 154 Next »

   Pharma Pub